You are here

A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Kweishan, Taoyuan, Taiwan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- The diagnosis of hip OA, which was having hip pain and meeting criteria for at least 2
of the following: a. Westergren erythrocyte sedimentation rate of radiographic femoral or acetabular osteophytes or c. radiographic joint space
narrowing

- Knee OA diagnosis required diagnosing (by modified American College of Rheumatology
criteria) OA of the knee with pain plus at least one of the following: a. Age> 50
years old, b. Stiffness evidence of OA of the knee, defined as presence of osteophytes or joint space
narrowing

- Symptomatic OA of the knee or hip was determined at the Baseline Visit, if the
Patient's Assessment of Arthritis Pain was at least 40 mm VAS, Patient's and the
Physician's Global Assessment of Arthritis was "poor" or "very poor"

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Use of NSAIDs or analgesics within 2 days (within 4 days for subjects taking
oxaprozin, piroxicam or full dose aspirin) before baseline arthritis assessments

NCT00648258
Pfizer
Completed
A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now